ARK Investment Management LLC 13D and 13G filings for Adaptive Biotechnologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 10:34 am Purchase | 2025-03-31 | 13G | Adaptive Biotechnologies Corporation ADPT | ARK Investment Management LLC | 7,732,570 5.200% | 1,664,761 (+27.44%) | Filing |
| 2025-05-07 11:42 am Sale | 2025-04-30 | 13G | Adaptive Biotechnologies Corporation ADPT | ARK Investment Management LLC | 6,067,809 3.990% | -3,356,265 (-35.61%) | Filing |
| 2025-02-14 11:23 am Sale | 2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | ARK Investment Management LLC | 9,424,074 6.390% | -3,382,439 (-26.41%) | Filing |
| 2024-01-29 4:00 pm Purchase | 2023-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | ARK Investment Management LLC | 12,806,513 8.850% | 3,605,268 (+39.18%) | Filing |
| 2023-02-10 10:25 am Purchase | 2022-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | ARK Investment Management LLC | 9,201,245 6.430% | 9,201,245 (New Position) | Filing |